The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Erythropoietin deficiency decreases vascular stability in mice
Open accessAbstract
Erythropoietin (Epo), a hormone known to stimulate bone marrow erythrocyte production, is widely used to treat anemia in patients at risk for vascular disease. However, the effects of Epo on angiogenesis are not well defined. We studied the role of Epo in a mouse model of retinopathy characterized by oxygen-induced vascular loss followed by hypoxia-induced pathological neovascularization. Without treatment, local retinal Epo levels were suppressed during the vessel loss phase. Administration of exogenous Epo prevented both vessel dropout and subsequent hypoxia-induced neovascularization. Early use of Epo also protected against hypoxia-induced retinal neuron apoptosis. In contrast, retinal Epo mRNA levels were highly elevated during the retinopathy neovascular phase. Exogenous late Epo treatment did not protect the retina, but rather enhanced pathological neovascularization. Epo's early protective effect occurred through both systemic retinal recruitment of proangiogenic bone marrow-derived progenitor cells and activation of prosurvival NF-kappaB via Epo receptor activation on retinal vessels and neurons. Thus early retinal Epo suppression contributed to retinal vascular instability, and elevated Epo levels during the proliferation stage contributed to neovascularization and disease. Understanding the role of Epo in angiogenesis is critical to timing its intervention in patients with retinopathy or other diseases in which pathological angiogenesis plays a significant role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
Self-citationPierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Self-citationDigicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A. M., & Dimmeler, S. (2003) · Blood · doi:10.1182/blood-2003-01-0223 · Cited by 845
Retinal angiogenesis in development and disease
Gariano, R. F., & Gardner, T. W. (2005) · Nature · doi:10.1038/nature04482 · Cited by 705
Grant, M. B., May, W. S., Caballero, S., Brown, G. A. J., Guthrie, S. M., Mames, R. N., Byrne, B. J., Vaught, T., Spoerri, P. E., Peck, A. B., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-607 · Cited by 665
Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.
Anagnostou, A., Lee, E. S., Kessimian, N., Levinson, R., & Steiner, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5978 · Cited by 569
Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M., & Remé, C. E. (2002) · Nature Medicine · doi:10.1038/nm723 · Cited by 518
Erythropoietin regulates endothelial progenitor cells
Bahlmann, F. H., de Groot, K., Spandau, J.-M., Landry, A. L., Hertel, B., Duckert, T., Boehm, S. M., Menne, J., Haller, H., & Fliser, D. (2004) · Blood · doi:10.1182/blood-2003-04-1284 · Cited by 504
Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy
Watanabe, D., Suzuma, K., Matsui, S., Kurimoto, M., Kiryu, J., Kita, M., Suzuma, I., Ohashi, H., Ojima, T., Murakami, T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041773 · Cited by 484
Wright, J. R., Ung, Y. C., Julian, J. A., Pritchard, K. I., Whelan, T. J., Smith, C., Szechtman, B., Roa, W., Mulroy, L., Rudinskas, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1514 · Cited by 428
Chong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Circulation · doi:10.1161/01.cir.0000039103.58920.1f · Cited by 381
Potential Role of Microglia in Retinal Blood Vessel Formation
Checchin, D., Sennlaub, F., Levavasseur, E., Leduc, M., & Chemtob, S. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1522 · Cited by 368
Otani, A., Kinder, K., Ewalt, K., Otero, F. J., Schimmel, P., & Friedlander, M. (2002) · Nature Medicine · doi:10.1038/nm744 · Cited by 328
Erythropoietin and VEGF Exhibit Equal Angiogenic Potential
Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., & Kuck, K.-H. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2426 · Cited by 317
Anti-Epo receptor antibodies do not predict Epo receptor expression
Elliott, S., Busse, L., Bass, M. B., Lu, H., Sarosi, I., Sinclair, A. M., Spahr, C., Um, M., Van, G., & Begley, C. G. (2006) · Blood · doi:10.1182/blood-2005-10-4066 · Cited by 305
Ritter, M. R., Banin, E., Moreno, S. K., Aguilar, E., Dorrell, M. I., & Friedlander, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29683 · Cited by 275
Bohlius, J., Langensiepen, S., Schwarzer, G., Seidenfeld, J., Piper, M., Bennett, C., & Engert, A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji087 · Cited by 238
The role of erythropoietin in regulating angiogenesis
Kertesz, N., Wu, J., Chen, T. H.-P., Sucov, H. M., & Wu, H. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.08.025 · Cited by 206
Effect of Erythropoietin Axotomy-Induced Apoptosis in Rat Retinal Ganglion Cells
Weishaupt, J. H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1039 · Cited by 193
Erythropoietin as an angiogenic factor
Ribatti, D., Vacca, A., Roccaro, A. M., Crivellato, E., & Presta, M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01245.x · Cited by 160
Kilic, Ü., Kilic, E., Soliz, J., Bassetti, C. L., Gassmann, M., & Hermann, D. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2493fje · Cited by 134
Anemia in diabetes: marker or mediator of microvascular disease?
Thomas, M. C. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0378 · Cited by 131
Li, F., Chong, Z. Z., & Maiese, K. (2004) · Neurosignals · doi:10.1159/000081963 · Cited by 115
Millet, I., Phillips, R. J., Sherwin, R. S., Ghosh, S., Voll, R. E., Flavell, R. A., Vignery, A., & Rincón, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15114 · Cited by 98
Pleiotropic Functions of Erythropoietin.
Sasaki, R. (2003) · Internal Medicine · doi:10.2169/internalmedicine.42.142 · Cited by 94
Katsura, Y., Okano, T., Matsuno, K., Osako, M., Kure, M., Watanabe, T., Iwaki, Y., Noritake, M., Kosano, H., Nishigori, H., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2252 · Cited by 92
Banin, E., Dorrell, M. I., Aguilar, E., Ritter, M. R., Aderman, C. M., Smith, A. C. H., Friedlander, J., & Friedlander, M. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1096 · Cited by 90
Self-citationThe High Prevalence of Anemia in Diabetes Is Linked to Functional Erythropoietin Deficiency
Thomas, M. C. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.05.003 · Cited by 49
Cited by
Hellström, A., Smith, L. E., & Dammann, O. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60178-6 · Cited by 1,304
Self-citationConnor, K. M., Krah, N. M., Dennison, R. J., Aderman, C. M., Chen, J., Guerin, K. I., Sapieha, P., Stahl, A., Willett, K. L., & Smith, L. E. H. (2009) · Nature Protocols · doi:10.1038/nprot.2009.187 · Cited by 738
Self-citationThe Mouse Retina as an Angiogenesis Model
Stahl, A., Connor, K. M., Sapieha, P., Chen, J., Dennison, R. J., Krah, N. M., Seaward, M. R., Willett, K. L., Aderman, C. M., Guerin, K. I., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5176 · Cited by 603
Self-citationChen, J., & Smith, L. E. H. (2007) · Angiogenesis · doi:10.1007/s10456-007-9066-0 · Cited by 602
Self-citationRetinopathy of prematurity: a review of risk factors and their clinical significance
Kim, S. J., Port, A. D., Swan, R., Campbell, J. P., Chan, R. V. P., & Chiang, M. F. (2018) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.04.002 · Cited by 579
Metadata
- Authors
- Chen, J., Connor, K. M., Aderman, C. M., & Smith, L. E. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-24
- Volume
- 118
- Issue
- 2
- Pages
- 526-33
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2023257711
- Cited by
- 280
- References
- 32
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.